* Orthofix Medical Inc OFIX.OQ reported quarterly adjusted
earnings of 7 cents per share for the quarter ended September
30, identical to the same quarter last year. The mean
expectation of five analysts for the quarter was for a loss
of 15 cents per share. Wall Street expected results to range
from -20 cents to -11 cents per share.
* Revenue rose 6.8% to $196.61 million from a year ago;
analysts
expected $196.52 million.
* Orthofix Medical Inc's reported EPS for the quarter was a
loss
of 71 cents.
* The company reported a quarterly loss of $27.39 million.
* Orthofix Medical Inc shares had risen by 17.8% this
quarter and
gained 36.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Orthofix Medical
Inc is $20.00
This summary was machine generated from LSEG data November 7 at
02:34 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.15 0.07 Beat
Jun. 30 2024 -0.19 0.05 Beat
Mar. 31 2024 -0.33 -0.13 Beat
Dec. 31 2023 -0.08 0.02 Beat